期刊文献+

结核菌特异性IFN-γ Elispot检测在活动性结核病和结核感染诊断中的应用 被引量:31

Clinical utility of an in-house interferon-γ Elispot assay for the diagnosis of active tuberculosis
下载PDF
导出
摘要 目的评价早期建立的结核菌特异性IFN-γ Elispot检测在活动性结核病和结核感染诊断中的应用价值。方法应用Elispot技术对1 154例结核病患者,52例非结核病肺部疾病对照,384例新发痰菌阳性结核患者的密切接触者,422例健康对照进行外周血结核菌特异性IFN-γ水平检测。对健康对照和密切接触者同时还进行平行的PPD皮试。结果结核患者Elispot检测的阳性率显著高于对照人群及结核病密切接触者。其中,血行播散性结核、继发性肺结核、结核性胸膜炎、结核性脑膜炎和其他肺外结核患者Elispot阳性率分别为91.3%,81.7%,86.5%,66.2%,89.8%。非结核病肺部疾病对照、健康对照和新发结核病人密切接触者Elispot阳性率分别为13.5%,15.4%和35.4%。在密切接触者筛查中,发现活动性结核病人17例,其中Elispot阳性14例(82.4%),PPD强阳性5人(29.4%);两者阳性率差异有统计学意义。结论在结合结核病史、结核病接触史以及临床表现的基础上,结核菌特异性IFN-γ的检测对活动性结核病诊断有一定的辅助诊断价值。通过检测结核高危人群结核菌特异性IFN-γ的水平,对早期发现活动性结核患者具有重要的价值。 Objective To appraise the clinical utility of an in-house interferon-γ Elispot assay for the diagnosis of active tuberculosis. Methods A in-house Elispot assay was used to determine Mycobacterium tuberculosis antigen-specific IFN-γ production in 1154 patients with active tuberculosis, 52 case controls with non-tuberculosis lung diseases, 422 healthy controls and 384 close contacts with newly diagnosed active tuberculosis patients. PPD skin test was used in parallel with Elispot in some healthy controls and close contacts. Results The positive rate of Elispot assay was significantly higher in the patients with tuberculosis than controls. In particular, 91.3% of patients with acute hematogenous disseminated tuberculosis, 81.7% of patients with secondary pulmonary tuberculosis, 86.5% of patients with tuberculous pleurisy, 66.2% of patients-with tuber-culous meningitis, and 89.8% of patients with extra-pulmonary tuberculosis were positive for IFN-γ Elispot assay. In comparison, the positive rates of Elispot assay in case controls, healthy controls and close contacts were 13.5%,15.4% and 35.4%, respectively. Seventeen individuals out of 384 close contacts were diagnosed with active tuberculosis. The positive rate (82.4%) of Elispot in these subjects was significantly than 20 mm. Conclusion Co exposure to tuberculosis and cli sis of active tuberculosis. nlc higher than that of PPD skin test (29.4%) with induration over ined with the information related to tuberculosis history, recent al manifestation, Elispot assay can be used to improve the diagno sis of active tuberculosis.
出处 《中国防痨杂志》 CAS 2010年第11期747-751,共5页 Chinese Journal of Antituberculosis
基金 国家自然科学基金资助项目(30872258) 国家十一五科技重大专项"艾滋病和病毒性肝炎等重大传染病防治"专题项目(2008ZX10003-005)
关键词 结核/诊断 干扰素Ⅱ型 免疫敏技术 tuberculosis/diagnosis interferon-γ immunoenzyme techniques
  • 相关文献

参考文献7

  • 1Drobniewski FA, Caws M, Gibson A, Young D. Modern laboratory diagnosis of tuberculosis [J]. Lancet Infect Dis, 2003, 3 (3): 141--147.
  • 2Menzies D, Pai M, Comstock G. Meta analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertain ty and recommendations for research[J]. Ann Intern Med, 2007,146(5) : 340-- 354.
  • 3杨倩婷,徐平,曾剑锋,朱秀云,黄华,邓群益,刘国辉,周伯平,陈心春.结核分枝杆菌IFN-γ酶联免疫斑点检测的建立和初步应用[J].中国防痨杂志,2009,31(3):144-148. 被引量:20
  • 4Chen X,Yang Q, Zhang M, Graner M,Zhu X, Larmonier N, Liao M,Yu W, Deng Q, Zhou B. Diagnosis of active tuberculosis in China using an in-house gamma interferon enzyme linked immunospot assay [J]. Clin Vaccine Immunol, 2009,16 (6) : 879 - 884.
  • 5杨绍基.传染病学[M].北京:人民卫生出版社,2006:5-116.
  • 6Diel R, Loddenkemper R, Nienhaus A. Evidence based comparison of commercial interferon-gamma release assays for detecting active TB: a meta-analysis [J]. Chest, 2010, 137 (4):952 968.
  • 7Park SY, Jeon K, Um SW, Kwon OJ, Kang ES, Koh WJ. Clinical utility of the QuantiFERON-TB Gold In Tube test for the diagnosis of active pulmonary tuberculosis [J]. Scand J Infect Dis, 2009,41 (11--12):818--822.

二级参考文献9

  • 1Drobniewski FA, Caws M, Gibson A, Young D. Modern laboratory diagnosis of tuberculosis[J]. Lancet Infection Disease, 2003, 3(3): 141-147.
  • 2Lalvani A, Nagvenkar P, Udwadia Z, Pathan AA, Wilkinson KA, Shastri JS, Ewer K, Hill AV, Mehta A, Rodrigues C. E-numeration of T cells specific for RDl-encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians[J]. The Journal of Infection Disease, 2001, 183(3): 469-477.
  • 3Nicol MP, Pienaar D, Wood K, Eley, B,Wilkinson R J, Hender son H, Smith L, Samodien S, Beatty D. Enzyme-linked immunospot assay responses to early secretary antigenic target 6, culture filtrate protein 10, and purified protein derivative among children with tuberculosis: implications for diagnosis and moni- toring of therapy [J]. Clinical Infection Disease, 2005, 40 (9) : 1501- 1308.
  • 4Gerald H,Mazurek MD, John Jereb MD, Phillip LoBue MD, Michael F, Iademarco MD, Beverly Metchock PhD, Andrew Vernon MD. Guidelines for using the QuantiFERON-TB Glod test for deteeting Myeobaeterium tuberculosis infection, United States[J]. MMWR. 2005, 54(15): 49-55.
  • 5Madhukar P,Shriprakash K, Keertan D. New tools and emerging technologies for the diagnosis of tuberculosis: Part I. Latent tuberculosis [J]. Expert Review of Molecular Diagnostics, 2006,6(3) : 413-422.
  • 6Johan V,Christian L,Jackson S. S, Jeremy G. W, George P. L, Mark T. D, Tumani C, Peter A, Keith P. W. J. M, Arnaud M. Tuberculosis contacts but not patients have higher gamma interferon responses to ESAT-6 than do community controls in the Gambia [J]. Infection And Immunity, 2001, 69 (10):6554 -6557.
  • 7Aandersen P, Munk ME, Pollock JM, Doherty TM. Specific immune-based diagnosis of tuberculosis [J]. The Lancet,2000, 356 (9235) : 1099- 10104.
  • 8Abu S. Mustafa, Raja'a AI-Attiyah, Sumaila N. M. Hanif, Fatema A. Shaban. Efficient Testing of Large Pools of Myco-bacterium tuberculosis RD1 Peptides and Identification of Major Antigens and Immunodominant Peptides Recognized by Human Thl Cells[J]. Clinical and Vaccine Immunology. 2008..(6): 916 -924.
  • 9Luca Richeldi. An Update on the Diagnosis of Tuberculosis Infection [J]. American Journal of Respiratory and Critical Care Medicine. 2006, 174 (7) :736-742.

共引文献25

同被引文献342

引证文献31

二级引证文献238

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部